Clinical Trials: Lung Cancer

Alabama

Huntsville; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Mobile; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Arizona

Scottsdale; Mayo Clinic
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Tucson; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

California

Corona; Compassionate Cancer Care Medical Group
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Duarte; City of Hope
CT Follow Up for Detection of Second Tobacco-Related Cancer

Duarte; City of Hope
SWOG S0229: A Randomized Trial Assessing the Effects of Exercise on Patients with Locally Advanced Lung Cancer Undergoing Curative Intent Combined Modality Therapy

Duarte; City of Hope
PHII-65 NCI #7103: A Phase II Study of AZD2171 (NSC #732208)in Patients with Malignant Mesothelioma

Duarte; City of Hope
The Relationship Between Coping, Gender and Psychological Adaptation in People with Lung Cancer

Fountain Valley; Compassionate Cancer Care Medical Group, Inc.
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Fresno; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

La Mesa; Cancer Center Oncology Medical Group
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

La Verne; Wilshire Oncology Medical Group, Inc.
A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients with Stage IIIB/IV Non-small Cell Lung Cancer who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens

La Verne; Accelerated Community Oncology Research Network, Inc. (ACORN)
A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients with Stage IIIB/IV Non-small Cell Lung Cancer who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens

Los Angeles; Offices of Sant Chawla, MD
Treatment research study for advanced non-small cell lung cancer

Los Angeles; Kenmar Research Institute, Llc
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Los Angeles; The Angeles Clinic & Research Institute
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Los Angeles; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Orange; Medical Oncology Care Associates
Treatment research study for advanced non-small cell lung cancer

Portland; Providence Portland Medical Center
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Poway; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Riverside; Compassionate Cancer Care Medical Group
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

San Francisco; Melanoma Center At St. Francis Memorial Hospital
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Various Cities; Research Center
Brain Metastases from Lung Cancer Study CEPO906A2227

Connecticut

Various Cities; Research Center
Brain Metastases from Lung Cancer Study CEPO906A2227

Delaware

Wilmington; Medical Oncology Hematology Consultants
Treatment research study for advanced non-small cell lung cancer

Florida

Boca Raton; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Boynton Beach; Hematology & Medical Oncology
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Gainesville; Gainesville Hematology/ Oncology Associates
Phase III clinical trial to evaluate the use effectiveness of Bevicizumab in combination with Tarceva in the treatment of lung cancer.

Miami Shores; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Ocala; Ocala Oncology Center
Treatment research study for advanced non-small cell lung cancer

Orlando; M D Anderson Cancer Center- Orlando
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Stuart; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Tampa; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Georgia

Atlanta; Georgia Cancer Specialists
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Illinois

Chicago; University Of Chicago Medical Center
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Decatur; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Elk Grove Village; Northwest Oncology & Hematology, SC
Treatment research study for advanced non-small cell lung cancer

Naperville; Hematology Oncology Consultants, Ltd.
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Park Ridge; Oncology Specialists, S.C.
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Rockford; Rockford Clinical Research Group
Treatment research study for advanced non-small cell lung cancer

Skokie; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Indiana

Beech Grove; American Health Network of Indiana LLC, Oncology Division
Phase III: Randomized, Double blind, Multicenter Study of Talabostat + Pemetrexed vs Pemetrexed + Placebo in Patients with Advanced (Stg IIB/IV) NSCLC after Failure of Platinum Based Chemotherapy

Indianapolis; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

New Albany; Cancer Care Center
Treatment research study for advanced non-small cell lung cancer

New Albany; Cancer Care Center
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Vincennes; Biomedical Research Alliance of New York
A clinical study involving an experimental dual drug approach to treating Advanced Non-Small Cell Lung Cancer (NSCLC) after failure of standard first-line chemotherapy.

Kentucky

Hazard; Kentucky Cancer Clinic
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Lexington; University of Kentucky Chandler Medical Center
Stage II or III non-small Cell Lung Cancer Research Study

Lexington; University of Kentucky Chandler Medical Center
Non-small Cell Lung Cancer Research Study

Lexington; University of Kentucky Chandler Medical Center
Lung Cancer Patients Needed for Research Study

Louisville; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Louisiana

Lake Charles; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Maryland

Frederick; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Hagerstown; The Cancer Center For Clinical Research
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Massachusetts

Various Cities; Research Center
Brain Metastases from Lung Cancer Study CEPO906A2227

Michigan

Flint; Genesys Hurley Cancer Institute
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Various Cities; Research Center
Brain Metastases from Lung Cancer Study CEPO906A2227

Minnesota

Minneapolis; University of Minnesota Medical School
Treatment research study for advanced non-small cell lung cancer

Minneapolis; The Cancer Center
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Mississippi

Pascagoula; The Regional Cancer Center
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Missouri

Columbia; Offices of Ali Khojesteh, MD
Treatment research study for advanced non-small cell lung cancer

Springfield; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

St. Louis; Washington University School Of Medicine
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

St. Louis; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Various Cities; Research Center
Brain Metastases from Lung Cancer Study CEPO906A2227

Montana

Missoula; Western Montana Clinic
Treatment research study for advanced non-small cell lung cancer

Nevada

Reno; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

New Hampshire

Lebanon; Norris Cotton Cancer Center
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

New Jersey

East Orange; VA Hospital of NJ Medical Center
Treatment research study for advanced non-small cell lung cancer

Hackensack; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

New York

Bronx; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Bronx; Biomedical Research Alliance of New York
Non – Small Cell Lung Cancer (NSCLC) - Adults and minors

Brooklyn; HemOnCare
Treatment research study for advanced non-small cell lung cancer

Buffalo; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

East Syracuse; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Lake Success; Biomedical Research Alliance of New York
Lung Cancer- Adults

Manhasset; Biomedical Research Alliance of New York
Lung Cancer Tissue Donation Program

Manhasset; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Mineola; Winthrop University Hospital Oncology Hematology Division
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

New York; Columbia University Medical Center
A phase II, open-label, non-randomized, multicenter, single agent study of intravenous sdx-102 for the treatment of patients with MTAP - deficient cancers.

New York; Biomedical Research Alliance of New York
Advanced Non-Small Cell Lung Cancer (NSCLC)

New York; Biomedical Research Alliance of New York
Non-Small Cell Lung Cancer (NSCLC)- Platinum-Based Chemotherapy

Poughkeepsie; Vassar Brothers Medical Center
A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (> 4.0 cm) - IIIA Non Small Cell Lung Cancer (NSCLC)

Rochester; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Staten Island; Biomedical Research Alliance of New York
Non - Small Cell Lung Cancer (NSCLC) - Adults and minors

Valhalla; New York Medical College
Treatment research study for advanced non-small cell lung cancer

Various Cities; Research Center
Brain Metastases from Lung Cancer Study CEPO906A2227

North Carolina

Fayetteville; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Winston Salem; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Winston-Salem; Wake Forest University Comprehensive Cancer Center
A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients with Stage IIIB/IV Non-small Cell Lung Cancer who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens

North Dakota

Bismarck; Odyssey Research Services
A Lung Cancer Research Study

Ohio

Canton; Gabrail Cancer Center
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Canton; N. Canton Medical Clinic Center
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Canton; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Columbus; Hematology Oncology Consultants, Inc
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Sylvania; Flower Hospital Cancer Center
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Various Cities; Research Center
Brain Metastases from Lung Cancer Study CEPO906A2227

Pennsylvania

Dunmore; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Langhorne; St. Mary Medical Center
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Lansdale; North Penn Hospital
Treatment research study for advanced non-small cell lung cancer

Sayre; Guthrie Foundation For Education And Research
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

South Carolina

Columbia; Wjb Va Medical Center
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Columbia; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Hilton Head; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Tennessee

Memphis; The West Cancer Clinic
A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients with Stage IIIB/IV Non-small Cell Lung Cancer who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens

Nashville; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Texas

Austin; Lone Star Oncology Consultants
Treatment research study for advanced non-small cell lung cancer

Houston; S. R. Burzynski Clinic
Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Squamous Cell Carcinoma Of The Lung

Houston; S. R. Burzynski Clinic
Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Bronchial Alveolar Carcinoma Of The Lung

Houston; S. R. Burzynski Clinic
Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Small Cell Carcinoma Of The Lung

Houston; S. R. Burzynski Clinic
Phase II Study Of Antineoplaston A10 And AS2-1 Capsules In Patients With Non Small Cell Lung Cancer

Houston; S. R. Burzynski Clinic
Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Adenocarcinoma Of The Lung

Houston; S. R. Burzynski Clinic
Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Large Cell, Undifferentiated Or Poorly Differentiated Carcinoma Of The Lung

Lubbock; Southwest Cancer Treatment And Research Center
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

San Antonio; South Texas Oncology and Hematology
Treatment research study for advanced non-small cell lung cancer

Utah

Salt Lake City; Huntsman Cancer Institute At The Univ. Of Utah
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Virginia

Abingdon; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Arlington; Arlington Fairfax Hematology and Oncology
Treatment research study for advanced non-small cell lung cancer

Charlottesville; University of Virginia
Lung Cancer Specimen Repository Protocol, Ancillary

Charlottesville; University of Virginia
Phase III trial of Carboplatin/Paclitaxel and thoracic radiation with or without Thalidomide in patients with stage III non-small cell lung cancer. HIC #8779

Charlottesville; University of Virginia
Phase III randomized multi-standard trial of Gemcitabin in combination with Carboplatin or Paclitaxel vs. Paclitaxel plus Carboplatin in patients with metastatic (stage IIIB pleural effusion or IV) non-small cell lung cancer. HIC #8775

Charlottesville; University of Virginia
The UVa Cancer Center seeks volunteers with non-small cell lung cancer for a

Norfolk; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Wisconsin

Milwaukee; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Various Cities; Research Center
Brain Metastases from Lung Cancer Study CEPO906A2227

Wyoming

Casper; Study Site
Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy

Laramie; Ivinson Memorial Hospital
Treatment research study for advanced non-small cell lung cancer

International

Belfort, France; Hopital General De Belfort
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Caen, France; Centre Francois Baclesse
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Marseille Cedex 9, France; Hopital Sainte Marguerite
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Nantes-Saint Herblain Cedex, France; Clcc Nantes Atlantique
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Rennes Cedex 9, France; Chu Pontchaillou - Service Pneumologie
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Strasbourg, France; Hopital Lyautey
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Ebensfeld, Germany; Bezirksklinikum Obermain
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Grosshansdorf, Germany; Krankenhaus Grosshansdorf
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Halle, Germany; Krankenhaus Martha-Maria Halle-Doelau Ggmbh
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Hamburg, Germany; Asklepios Klinik Harburg
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Koeln, Germany; Lungenklinik Koeln-Merheim
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Leipzig, Germany; Universitaetsklinikum Leipzig
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Mainz, Germany; Klinikum Der Johannes-Gutenberg-Universitaet
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Muenchen, Germany; Klinikum Rechts Der Isar Der Tum
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Hyderabad, India; Nizam'S Institute Of Medical Sciences
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Manipal, Karnataka, India; Shirdi Sai Baba Cancer Hospital, Kmc
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Navrangpura, Ahmedabad, Gujarat, India; Vedanta Near Samved Hospital
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Trivandrum, Kerala, India; Regional Cancer Institute
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Vellore, India; Christian Medical College
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Genova, Italy; Istituto Nazionale Per La Ricerca Sul Cancro
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Perugia, Italy; Azienda Ospedaliera Di Perugia
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Roma, Italy; A.O San Camillo - Forlanini
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Siena, Italy; Policlinico Santa Maria Alle Scotte
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Torino, Italy; Univ. Of Turin, Azienda Ospedaliera S. Luigi Gonzaga
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Gdansk, Poland; Klinika Onkologii I Radioterapii Akademickie Cent. Kliniczne
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Krakow, Poland; Klinika Nowotworow Ukladowych
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Krakow, Poland; Oddzial Onkologii Klinicznej
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Olsztyn, Poland; Oddzial Chemioterapii
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Poznan, Poland; Oddzial Onkologii Klinicznej
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Szczecin, Poland; Oddzial Chemioterapii
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Arkhangelsk, Russian Federation; State Institution Of Healthcare
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Chelyabinsk, Russian Federation; Chelyabinsk Regional Oncology Dispensary
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Ivanovo, Russian Federation; Ivanovo Regional Oncology Dispensary
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Lipetsk, Russian Federation; Municipal Institute Of Healthcare
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Lipetsk, Russian Federation; Lipetsk Regional Oncology Dispensary
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Moscow, Russian Federation; Research Institute Of Oncology
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Moscow, Russian Federation; City Clinical Hospital #57
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Moscow, Russian Federation; Cancer Research Centre Rams
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Pyatigorsk, Russian Federation; Stavropol Territory Clinical Oncologic Dispensary
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Saint-Petersburg, Russian Federation; City Psychoneurological Dispensary #7 With Hospital
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

St. Petersburg, Russian Federation; Leningrad Regional Clinical Hospital
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

St. Petersburg, Russian Federation; Russian Military Medical Academy
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

St. Petersburg, Russian Federation; City Clinical Oncology Dispensary, Chest Departmen
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Tomsk, Russian Federation; Scientific Research Center For Oncology
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Edinburgh, Scotland; University of Edinburgh, Division of Onclogy
A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients with Stage IIIB/IV Non-small Cell Lung Cancer who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens

Barcelona, Spain; Research Site:
A Study of Risk Stratification in Patients With Suspected Lung Cancer.

Manresa, Spain; Research Site:
A Study of Risk Stratification in Patients With Suspected Lung Cancer.

San Sebastian, Spain; Research Site:
A Study of Risk Stratification in Patients With Suspected Lung Cancer.

Santiago, Spain; Research Site:
A Study of Risk Stratification in Patients With Suspected Lung Cancer.

Sevilla, Spain; Research Site:
A Study of Risk Stratification in Patients With Suspected Lung Cancer.

Dnipropetrovsk, Ukraine; City Clinical Hospital #4
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Donetsk, Ukraine; Regional Antineoplastic Center
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Kharkov, Ukraine; Regional Clinical Oncology Dispensary
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Kharkov, Ukraine; Regional Pediatric Hospital #1
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Kiev, Ukraine; City Oncology Hospital
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Lviv, Ukraine; Lviv State Oncology Regional Treatment And Diagnostic Centre
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Ternopol, Ukraine; Ternopil State Medical University
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Uzhgorod, Ukraine; Regional Oncology Clinical Dispensary
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

Aberdeen, United Kingdom; Aberdeen Royal Infirmary
A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients with Stage IIIB/IV Non-small Cell Lung Cancer who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens

Dundee, United Kingdom; Division of Cancer Medicine, Biomedical Research Centre
A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients with Stage IIIB/IV Non-small Cell Lung Cancer who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens

Glasgow, United Kingdom; Department of Medical Oncology
A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients with Stage IIIB/IV Non-small Cell Lung Cancer who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens

Newcastle upon Tyne, United Kingdom; Department of Medical Oncology
A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients with Stage IIIB/IV Non-small Cell Lung Cancer who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens

Sheffield, United Kingdom; Department of Oncology
A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients with Stage IIIB/IV Non-small Cell Lung Cancer who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens

Sutton, Surrey, United Kingdom; Department of Medicine
A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients with Stage IIIB/IV Non-small Cell Lung Cancer who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens